| ASPsiRNA ID | Pairing of target region (top) and ASP-siRNA (bottom) | Efficacy (mut)(%) | Efficacy (wt) (%) | Diff | Gene | Disease | Mutation | RefSNP | Analysis | Pubmed ID |
|---|---|---|---|---|---|---|---|---|---|---|
| aspsirna2111 | UGUUGGCGUAGGCAAGAGU ACAACCGCAUCCGUUCUCA |
2 | 15 | -13 | KRAS | Cancer | c.35G>T,p.Gly12Val | rs12191352 | 
|
|
| aspsirna2132 | UGUUGGCGUAGGCAAGAGU ACAACCGCAUCCGUUCUCA |
2 | 15 | -13 | KRAS | Cancer | c.35G>T,p.Gly12Val | rs12191352 |
|
|
| aspsirna0351 | AAGUUCCAGCUGGGAUACC UUCAAGGUCGACCCUAUGG |
45 | 0 | 45 | COL3A1 | Vascular Ehlers-Danlos Syndrome (vEDs) | c.764G>T,p.Gly255Val | rs58777960 |
|
|
| aspsirna3638 | UCAGAGAGAUCCUCAUAAA AGUAUCUCUAGGAGUAUUU |
90 | 49 | 41 | PPIB/Cyclophilin B | PPIB-Related Osteogenesis Imperfecta (Type IX) | NA | NA |
|
|
| aspsirna3791 | AAAGUUGCGCGGAGGAGUU UUUAAACGCGCCUCCUCAA |
90 | 22 | 68 | PPIB/Cyclophilin B | PPIB-Related Osteogenesis Imperfecta (Type IX) | NA | NA |
|
